Cerebral Inc., a fast-growing mental health and medication management startup based in San Francisco, recently announced it will stop prescribing most controlled substances to new patients starting this Friday....
A Shift From Acquisitions to Strategic Partnerships
While mergers and acquisitions have dominated the headlines in behavioral health, another powerful model is steadily gaining traction:...
Virtual medication-assisted treatment (Virtual MAT) providers have witnessed a transformative moment during the COVID-19 pandemic, propelled by regulatory changes that dramatically expanded access to...
A new bipartisan effort in Congress aims to bring long-overdue digital modernization to the behavioral health sector. The Behavioral Health Information Technologies (BHIT) Now...
San Francisco-based telemental health provider Cerebral has entered the rapidly expanding field of virtual opioid use disorder treatment with the launch of a new...
Florida has made a significant regulatory advancement by amending its state code to allow certain controlled substances to be prescribed via telehealth. This change...
A newly published study highlights a significant healthcare crisis in Medicare substance use disorder treatment, affecting millions of beneficiaries across the United States. Despite...